World Journal of Pharmaceutical
and Medical Research

( An ISO 9001:2015 Certified International Journal )

An International Peer Reviewed Journal for Pharmaceutical and Medical Research and Technology
An Official Publication of Society for Advance Healthcare Research (Reg. No. : 01/01/01/31674/16)
ISSN (O) : 2455-3301
ISSN (P) : 3051-2557
IMPACT FACTOR: 7.533

ICV : 78.6

World Journal of Pharmaceutical and Medical Research (WJPMR) has indexed with various reputed international bodies like : Google Scholar , Index Copernicus , SOCOLAR, China , Indian Science Publications , Cosmos Impact Factor , Research Bible, Fuchu, Tokyo. JAPAN , Scientific Indexing Services (SIS) , UDLedge Science Citation Index , International Impact Factor Services , International Society for Research Activity (ISRA) Journal Impact Factor (JIF) , International Innovative Journal Impact Factor (IIJIF) , Scientific Journal Impact Factor (SJIF) , Global Impact Factor (In Process) , Digital Online Identifier-Database System (DOI-DS) , Science Library Index, Dubai, United Arab Emirates , Eurasian Scientific Journal Index (ESJI) , International Scientific Indexing, (ISI) UAE , IFSIJ Measure of Journal Quality , Web of Science Group (Under Process) , Directory of Research Journals Indexing , Scholar Article Journal Index (SAJI) , International Scientific Indexing ( ISI ) , Scope Database , Academia , Doi-Digital Online Identifier , ISSN National Centre , Zenodo Indexing , International CODEN Service, USA , 

Abstract

A RANDOMIZED COMPARATIVE CLINICAL STUDY TO DETERMINE THE EFFICACY OF DADRUKANDVADI LEPA AND DURVADI LEPA IN DADRU

Shubham*, Ashwini S. G., Prashanth Bhat

ABSTRACT

Dadru is a common skin condition in Ayurveda, characterized by Kandu (itching), Raga (erythema), Pidaka (eruption), and Utsanna mandala (elevated lesions), clinically correlating with superficial fungal infections like Tinea (dermatophytosis). This study aimed to comparatively evaluate the therapeutic efficacy of two classical topical formulations, Dadrukandvadi Lepa and Durvadi Lepa. A single-blind, randomized comparative clinical study was conducted on 60 subjects diagnosed with Dadru. Subjects were assigned via block randomization into two equal groups (n=30). Group A received Dadrukandvadi Lepa, and Group B received Durvadi Lepa. Both formulations were applied externally with Takra for 20 days, with evaluations at baseline, 10th, and 20th days. Both groups demonstrated highly significant clinical improvements (p < 0.001) across all parameters. Group A achieved its highest relief in Rookshata (83.9%) and Kandu (76.0%). Group B achieved outstanding responses in Daha (70.5%), Raga (70.4%), and Utsanna Mandala (69.5%). Inter-group analysis showed Raga was the only parameter with a statistically significant difference (p = 0.0379), demonstrating Durvadi Lepa's superior anti-erythema efficacy. Overall mean therapeutic improvement was highly comparable (64.72% in Group A; 64.41% in Group B). Both topical interventions are highly safe, cost-effective, and efficacious. Dadrukandvadi Lepa provides relatively superior action for Kapha-Pitta dominant presentations (pronounced itching and dryness), while Durvadi Lepa is highly indicated when Pitta-Kapha dominates (marked erythema and burning).

[Full Text Article]    [Download Certificate]

Powered By WJPMR | All Right Reserved

Count age days